Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1999
03/09/1999CA1340421C Sythesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
03/08/1999CA2242476A1 Novel compositions containing cyclosporin
03/08/1999CA2209893A1 Lantibiotic from streptococcus mutans, method of production and use thereof
03/04/1999WO1999010537A1 A tumor suppressor designated ts10q23.3
03/04/1999WO1999010525A1 A method of treating cancer
03/04/1999WO1999010523A1 A method of treating cancer
03/04/1999WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
03/04/1999WO1999010510A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999WO1999010509A1 Polynucleotide inhibition of rna destabilization and sequestration
03/04/1999WO1999010504A2 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
03/04/1999WO1999010502A1 Human nucleotide pyrophosphohydrolase
03/04/1999WO1999010501A1 Apoptosis-associated nuclease cpan
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010494A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses
03/04/1999WO1999010492A1 Adipocyte-specific protein homologs
03/04/1999WO1999010491A1 New human g-protein coupled receptor
03/04/1999WO1999010487A2 Novel transcriptional regulators and uses therefor
03/04/1999WO1999010486A2 Mdm2-specific antisense oligonucleotides
03/04/1999WO1999010484A1 Rtd receptor
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010478A1 Mammalian common lymphoid progenitor cell
03/04/1999WO1999010382A1 Peptides which elicit cytotoxic t cellular immunity
03/04/1999WO1999010381A1 Collagen mimics
03/04/1999WO1999010380A1 Human spa-1 protein and gene coding for the same
03/04/1999WO1999010379A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
03/04/1999WO1999010378A1 Pompilid wasp-derived neuropeptides
03/04/1999WO1999010374A1 Cyclosporin a conjugates and uses therefor
03/04/1999WO1999010373A1 Non-immunosuppressive cyclosporins and their use in the prevention and treatment of hiv infection
03/04/1999WO1999010371A2 Cyclopeptide derivatives as adhesion inhibitors
03/04/1999WO1999010369A1 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010013A1 The use of insulin-like growth factor-i in muscle
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010011A1 Dried biologically or therapeutically active preparations
03/04/1999WO1999010009A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999WO1999010007A1 Methods and compositions for enhanced wound healing
03/04/1999WO1999010006A1 Therapy for staphylococcus aureus
03/04/1999WO1999010004A2 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
03/04/1999WO1999010003A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999WO1999010001A1 Carcinostatic agents
03/04/1999WO1999009992A1 Neovascularization promoters
03/04/1999WO1999009991A1 Novel amide derivatives
03/04/1999WO1999009982A1 Prevention of adhesions and excessive scar formation using angiogenesis inhibitors
03/04/1999WO1999009912A1 Intravascular apparatus and method
03/04/1999WO1999009835A1 Use of an anti-microbial composition
03/04/1999WO1998056408A3 Inhibitors of microbial adherence or invasion as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
03/04/1999WO1998056407A3 Fibronectin antagonists as therapeutic agents and broad-spectrum enhancers of antibiotic therapy
03/04/1999WO1998055616A3 Brca2 locus-associated protein
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
03/04/1999WO1998055600A3 New human ribonuclease
03/04/1999WO1998055506A3 Thrombin-inhibiting peptide
03/04/1999WO1998055455A3 Modification of platelet action by fibrinogen-coated particles
03/04/1999WO1998054211A3 Cyclodepsipeptides and pharmaceutical compositions containing them
03/04/1999WO1998051345A3 Method for dislodging infiltrated leukocytes from a tissue
03/04/1999DE19737105A1 Neue gewebsspezifische Calpaine, ihre Herstellung und Verwendung New tissue-specific calpain, their preparation and use
03/04/1999DE19735587A1 Peptid mit radioprotektiver Wirkung Peptide with radioprotective effect
03/04/1999DE19735105A1 New fusion protein
03/04/1999CA2302780A1 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
03/04/1999CA2302525A1 Follistatin-3
03/04/1999CA2302387A1 29 human secreted proteins
03/04/1999CA2302317A1 A process for inhibiting complement activation via the alternative pathway
03/04/1999CA2302023A1 Angiogenesis promoter
03/04/1999CA2301880A1 A method of treating cancer
03/04/1999CA2301879A1 Tuberculosis vaccine
03/04/1999CA2301877A1 A method of treating cancer
03/04/1999CA2301847A1 Rtd receptor
03/04/1999CA2301840A1 Peptides which elicit cytotoxic t cellular immunity
03/04/1999CA2301816A1 Mdm2-specific antisense oligonucleotides
03/04/1999CA2301815A1 New tissue-specific calpaines, their production and their use
03/04/1999CA2301780A1 Androgen activity antagonists as therapies for anorexia, anorexia nervosa, and disorders characterized by a pathologically underweight condition
03/04/1999CA2301779A1 Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use
03/04/1999CA2301661A1 Human nucleotide pyrophosphohydrolase
03/04/1999CA2301660A1 Adipocyte-specific protein homologs
03/04/1999CA2301589A1 Therapy for staphylococcus aureus
03/04/1999CA2301566A1 N-acylated lipophilic amino acid derivatives
03/04/1999CA2301514A1 Dried biologically or therapeutically active preparations
03/04/1999CA2301498A1 New human g-protein coupled receptor
03/04/1999CA2301199A1 A tumor suppressor designated ts10q23.3
03/04/1999CA2301182A1 Cyclopeptide derivatives
03/04/1999CA2300376A1 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999CA2300370A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
03/04/1999CA2242260A1 Spo0j1
03/04/1999CA2242258A1 Novel compounds
03/04/1999CA2242254A1 Novel tig
03/03/1999EP0899339A1 The Chlamydia trachomatis Glutamyl-tRNAGln amidotransferase subunit ratB
03/03/1999EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS)
03/03/1999EP0899337A2 FtsY polynucleotides and polypeptides of Stapyloccoccus aureus belonging to the signal recognition protein family
03/03/1999EP0899335A2 MurB gene from Staphylococcus aureus
03/03/1999EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae
03/03/1999EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus
03/03/1999EP0899332A2 The G-protein coupled receptor HFIAO41
03/03/1999EP0899331A1 Purified proteolytic enzyme and procedure for purification
03/03/1999EP0899330A1 Polypeptide isolated from the epidermis and its use
03/03/1999EP0899329A2 DextranaseB gene from Streptococcus pneumoniae
03/03/1999EP0899271A1 Process for inducing therapeutically active proteins
03/03/1999EP0898968A1 Antitumor agent comprising a complex of an oxidoreductase and a polymer and a substrate of the enzyme
03/03/1999EP0898967A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities
03/03/1999EP0898963A2 Congestive heart failure treatment
03/03/1999EP0898619A1 Chimeric cell-surface receptors that undergo antigen-induced association
1 ... 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 2550 2551 2552 2553 2554 2555 ... 3163